• G Ma, W J Brady, M Pollack, and T C Chan.
• Department of Emergency Medicine, University of California San Diego Medical Center, 200 West Arbor Drive #8676, San Diego, CA 92130-8676, USA.
• J Emerg Med. 2001 Feb 1; 20 (2): 145-52.

AbstractToxicity from the digitalis family of cardiac glycoside medications remains common. Successful treatment depends on early recognition; however, the diagnosis of potentially life-threatening toxicity remains difficult because the clinical presentation is often nonspecific and subtle. The hallmark of cardiac toxicity is increased automaticity coupled with concomitant conduction delay. Though no single dysrhythmia is always present, certain aberrations such as frequent premature ventricular beats, bradydysrhythmias, paroxysmal atrial tachycardia with block, junctional tachycardia, and bidirectional ventricular tachycardia are common. Treatment depends on the clinical condition rather than serum drug level. Management varies from temporary withdrawal of the medication to administration of digoxin-specific Fab fragments for life-threatening cardiovascular compromise.

22 keywords...

hide…